|CYIG -- USA Stock|| |
USD 0.82 0.03 3.53%
Mr. Shao Zecheng is Vice President of Shandong Spring Pharmaceutical Co. Ltd., Mr. Shao was involved with capital business for over 10 years. Since 2007 he was employed as vice president of the Company subsidiary, Shandong Spring Pharmaceutical Co., Ltd. From 1997 to 2007, Mr. Shao was employed as Minister of Korean Daewoo Group. During the period, he successfully managed, designed and programmed 2 ERP projects and cooperated with the other departments of the company in the past years. All the projects were released on schedule, with high quality that helped the company business grow. From 1994 to 1997, Mr. Shao was a computer engineer at the Shandong Huajin Group. In 1994, Mr. Shao received a diploma from the Shandong Teachers University. In 2000, he received the Super Development Engineer Certificate for PoweBuilder in Sybase Center.
Age: 42 VP Since 2007
86 40 6282 3188 http://www.yctgroup.com
The company has return on total asset (ROA)
of 9.44 %
which means that it generated profit of $9.44 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE)
of 12.01 %
meaning that it created $12.01 on every $100 dollars invested by stockholders.
China YCT International Group, Inc., through its subsidiaries, engages in the research, development, manufacture, and sale of Chinese medicines primarily made from ginseng extract in the Peoples Republic of China. China YCT International Group, Inc. was incorporated in 1989 and is based in Sishui, the Peoples Republic of China. China YCT is traded on OTC Market in USA.China YCT International Group (CYIG) is traded on OTC Market in USA. It is located in Economic Development Zone and employs 279 people.
China YCT International Leadership Team
|Zecheng Shao, VP|
|Qiang Zhang, Chief Admin. Officer|
|Chuanming Li, CFO|
|Tinghe Yan, Chairman and CEO|
|Dong Li, Director|
|Wengao Zhang, Independent Director|
|Hanwei Zhou, General Manager of Shandong Spring Pharmaceutical|
|Xuzhong Ding, Chief Marketing Officer|
|Robert Fanella, Independent Director|
|John Wallace, Independent Director|
|Sun Maogang, General Manager of Shandong Spring Pharmaceutical|
|Jirui Zhang, Director|
Stock Performance Indicators
Macroaxis portfolio users are unresponsive in their opinion about investing in China YCT International Group. What is your opinion about investing in China YCT International Group? Are you bullish or bearish?
and pair trading evaluation for China YCT and Apple
. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Check also Trending Equities
. Please also try Idea Breakdown
module to analyze constituents of all macroaxis ideas. macroaxis investment ideas are predefined, sector-focused investing themes.